Unichem gets four USFDA observations for Pithampur manufacturing facility

01 Aug 2018 Evaluate

Unichem Laboratories has received four observations from the US Food and Drug Administration (USFDA) for its API manufacturing facility at Pithampur, Madhya Pradesh. The facility was inspected by USFDA from July 23 to July 27, 2018.

Four observations were made which do not impact continuity of the company's business and its manufacturing activity. The company proposes to respond to these observations within 15 business days. The Pithampur facility manufactures API for use in the production of formulations that are exported to the USA.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world.

Unichem Lab Share Price

552.00 4.30 (0.79%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.